Skip to main content
. 2016 Sep;28(3):131–137.

Figure 3.

Figure 3

Survival of participants with RDS and sepsis receiving nasal oxygen vs. bCPAP. (Left) Fraction of eligible study subjects with a primary diagnosis of respiratory distress syndrome (RDS) who survived to discharge and received nasal oxygen or bCPAP. (Right) Fraction of eligible study subjects with a co-morbidity of sepsis who survived to discharge and received nasal oxygen or bCPAP.

doi:10.1371/journal.pone.0086327.g003